PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5650.01%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-5650.01%
Negative operating income growth while Healthcare median is 0.24%. Seth Klarman would check if structural or cyclical issues are at play.
-40472.45%
Negative net income growth while Healthcare median is 1.97%. Seth Klarman would investigate factors dragging net income down.
-3050.00%
Negative EPS growth while Healthcare median is 5.56%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-3050.00%
Negative diluted EPS growth while Healthcare median is 5.26%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
1209.23%
Share growth above Healthcare median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
1209.23%
Diluted share growth above 2x Healthcare median. Jim Chanos would suspect undue issuance or heavy employee stock compensation.
No Data
No Data available this quarter, please select a different quarter.
-33934.54%
Negative OCF growth while Healthcare median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-40083.77%
Negative FCF growth while Healthcare median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-51.16%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-51.16%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-51.16%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-117.44%
Negative 10Y net income/share CAGR vs. Healthcare median of 20.23%. Seth Klarman might see a fundamental problem if peers maintain growth.
-117.44%
Negative 5Y CAGR while Healthcare median is 5.10%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-117.44%
Negative 3Y CAGR while Healthcare median is 4.84%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
74.46%
Equity/share CAGR of 74.46% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
74.46%
5Y equity/share CAGR of 74.46% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
74.46%
3Y equity/share CAGR of 74.46% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
110905.89%
AR growth of 110905.89% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
7369.40%
Asset growth of 7369.40% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
552.07%
BV/share growth of 552.07% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41942.29%
SG&A growth of 41942.29% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.